Pharming (PHAR) Other Accumulated Expenses (2019 - 2023)
Historic Other Accumulated Expenses for Pharming (PHAR) over the last 5 years, with Q3 2023 value amounting to -$10.9 million.
- Pharming's Other Accumulated Expenses fell 4510604.68% to -$10.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$10.9 million, marking a year-over-year decrease of 4510604.68%. This contributed to the annual value of -$8.7 million for FY2022, which is 25707058.82% down from last year.
- According to the latest figures from Q3 2023, Pharming's Other Accumulated Expenses is -$10.9 million, which was down 4510604.68% from -$6.0 million recorded in Q2 2023.
- In the past 5 years, Pharming's Other Accumulated Expenses registered a high of $14.7 million during Q2 2021, and its lowest value of -$12.6 million during Q2 2022.
- Its 5-year average for Other Accumulated Expenses is -$880584.2, with a median of -$10976.0 in 2021.
- As far as peak fluctuations go, Pharming's Other Accumulated Expenses crashed by 39850535.25% in 2022, and later soared by 5211.39% in 2023.
- Quarter analysis of 5 years shows Pharming's Other Accumulated Expenses stood at $4.1 million in 2019, then tumbled by 99.87% to $5175.7 in 2020, then tumbled by 57.63% to $2193.0 in 2021, then crashed by 398505.35% to -$8.7 million in 2022, then dropped by 24.93% to -$10.9 million in 2023.
- Its Other Accumulated Expenses was -$10.9 million in Q3 2023, compared to -$6.0 million in Q2 2023 and -$8.7 million in Q4 2022.